Informations cliniques
Depuis des années, on observe une propagation mondiale d’une multitude de nouveaux virus et autres agents pathogènes. Les maladies qui y sont liées sont regroupées sous le terme « maladies infectieuses émergentes ». Il s’agit de maladies infectieuses qui apparaissent pour la première fois dans une population ou dont l’incidence et la répartition régionale augmentent rapidement. Les virus transmis par les arthropodes, également appelés arbovirus, font partie des agents pathogènes les plus fréquents chez l’homme dans le monde et constituent un problème croissant depuis quelques décennies. Les arbovirus ont une grande capacité de mutation et d’adaptation, c’est pourquoi ils provoquent souvent des épidémies. Outre la dengue et le chikungunya, il faut mentionner ici la fièvre Zika qui s’est propagée en 2015/2016 sur une grande partie du continent sud-américain. Cependant, des épidémies saisonnières dues à des arbovirus tels que le virus du Nil occidental ou le chikungunya ont également eu lieu dans le passé dans des zones climatiques tempérées comme l’Europe. Les évolutions cliniques des maladies provoquées par les arbovirus sont très similaires, de sorte qu’un diagnostic ne peut généralement pas être posé sur la seule base du tableau clinique.
Outre les arbovirus mentionnés, il existe une multitude d’autres agents pathogènes qui pourraient également déclencher des épidémies importantes et devenir ainsi un problème de santé publique mondial majeur - comme récemment le virus SARS-CoV-2, qui a entraîné une pandémie.
Diagnostic
Le diagnostic de ces maladies représente un défi particulier, car il n’existe souvent aucun système de test diagnostique approprié disponible dans le commerce pour les paramètres correspondants. En général, une infection par un agent pathogène de maladie émergente est diagnostiquée sur la base de critères cliniques, épidémiologiques et de résultats de laboratoire. Le diagnostic de laboratoire repose sur des méthodes de détection directes et indirectes. Le diagnostic de laboratoire revêt une importance particulière pour l’examen des voyageurs de retour de zones d’endémie et pour le dépistage de groupes de population plus importants en cas d’épidémie ou de pandémie.
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | 5/25/50/100/175/230 U/ml | IgG |
96 x 01 |
EI 2661-9601-2L G |
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgM |
96 x 01 |
EI 2661-9601-2L M | |
| IIFT | West Nile virus (WNV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2662-1005 G FI 2662-1005 M FI 2662-1010 G FI 2662-1010 M |
|
| IIFT | Japanese encephalitis virus (JEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM |
10 x 05 10 x 05 |
FI 2663-1005 G FI 2663-1005 M |
|
| IIFT | Yellow fever virus (YFV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2665-1005 G FI 2665-1005 M FI 2665-1010 G FI 2665-1010 M |
|
| IIFT |
Mosaic Dengue virus types 1 - 4 (DENV) |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FI 266a-1005-1 G FI 266a-1005-1 M FI 266a-1010-1 G FI 266a-1010-1 M FI 266a-2005-1 G FI 266a-2005-1 M |
|
| IIFT |
Sandfly fever virus Mosaic 1 types Sicilian, Naples, Toscana, Cyprus |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 277a-1005-1 G FI 277a-1005-1 M FI 277a-1010-1 G FI 277a-1010-1 M |
|
| IIFT |
Hantavirus Mosaic 1 types Hantaan (HTNV), Sin Nombre (SNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 278h-1005-1 G FI 278h-1005-1 M FI 278h-1010-1 G FI 278h-1010-1 M |
|
| IIFT |
Hantavirus Mosaic 2 Eurasia types Hantaan (HTNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected and non- infected cells |
EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 278h-1005-2 G FI 278h-1005-2 M FI 278h-1010-2 G FI 278h-1010-2 M |
|
| IIFT |
Hantavirus Mosaic 3: America types Sin Nombre (SNV), Andes (ANDV) |
2 BIOCHIPs per field: infected cells |
EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 278m-1005-3 G FI 278m-1005-3 M |
|
| IIFT | Chikungunya virus (CHIKV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 20 x 05 20 x 05 |
FI 293a-1005 G FI 293a-1005 M FI 293a-1010 G FI 293a-1010 M FI 293a-2005 G FI 293a-2005 M |
|
| IIFT |
Arbovirus Fever Mosaic 1 Chikungunya virus (CHIKV) Japanese encephalitis virus (JEV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 293a-1005-1 G FI 293a-1005-1 M FI 293a-1010-1 G FI 293a-1010-1 M |
|
| IIFT | Yellow fever virus (YFV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI |
10 x 05 10 x 05 |
FR 2665-1005 G FR 2665-1005 M |
|
| IIFT |
Mosaic Dengue virus types 1 - 4 (DENV) EUROPattern |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 266a-1005-1 G FR 266a-1005-1 M FR 266a-1010-1 G FR 266a-1010-1 M |
|
| IIFT |
Sandfly fever virus Mosaic 1 EUROPattern types Sicilian, Naples, Toscana, Cyprus |
4 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 277a-1005-1 G FR 277a-1005-1 M |
|
| IIFT |
Hantavirus Mosaic 1 EUROPattern types Hantaan (HTNV), Sin Nombre (SNV), Puumala (PUUV), Dobrava (DOBV), Seoul (SEOV), Saaremaa (SAAV) |
6 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 278h-1005-1 G FR 278h-1005-1 M |
|
| IIFT |
Hantavirus Mosaic 3: America EUROPattern types Sin Nombre (SNV), Andes (ANDV) |
2 BIOCHIPs per field: infected cells |
EU 14 |
IgG PI IgM PI |
10 x 05 10 x 05 |
FR 278m-1005-3 G FR 278m-1005-3 M |
|
| IIFT | Chikungunya virus (CHIKV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 293a-1005 G FR 293a-1005 M FR 293a-1010 G FR 293a-1010 M |
|
| ELISA |
Anti-West Nile Virus ELISA (IgG) WNV |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2662-9601 G |
| ELISA |
Anti-West Nile Virus ELISA (IgM) WNV |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
semi-quantitative | IgM |
96 x 01 |
EI 2662-9601 M |
| ELISA |
Avidity: Anti-West Nile Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2662-9601-1 G |
| ELISA |
Anti-JEV ELISA (IgG) Japanese encephalitis virus |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2663-9601 G |
| ELISA |
Anti-JEV ELISA (IgM) Japanese encephalitis virus |
antigen-coated microplate wells |
detergent-extracted glycoprotein E from the membrane fraction of human cells |
semi-quantitative | IgM |
96 x 01 |
EI 2663-9601 M |
| ELISA | Anti-Usutu Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant glycoprotein E of Usutu virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2667-9601 G |
| ELISA | Anti-Dengue Virus Type 1-4 ELISA (IgG) |
antigen-coated microplate wells |
preparation of Dengue virus particles and recombinant glycoprotein E of types 1-4 |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 266a-9601-1 G |
| ELISA | Anti-Dengue Virus Type 1-4 ELISA (IgM) |
antigen-coated microplate wells |
preparation of Dengue virus particles and recombinant glycoprotein E of types 1-4 |
semi-quantitative | IgM |
96 x 01 |
EI 266a-9601-1 M |
| ELISA | Anti-Dengue Virus NS1 ELISA 2.0 (IgG) |
antigen-coated microplate wells |
recombinant NS1 antigen from Dengue virus |
IgG |
96 x 01 |
EI 266a-9601-3 G | |
| ELISA | Anti-Oropouche Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant Oropouche-nucleocapsid protein |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2771-9601 G |
| ELISA | Anti-Oropouche Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant Oropouche-nucleocapsid protein |
semi-quantitative | IgM |
96 x 01 |
EI 2771-9601 M |
| ELISA | Anti-Toscana virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant N-protein from Toscana virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 277c-9601 G |
| ELISA | Anti-Hanta Virus Pool 1 "Eurasia" ELISA (IgG) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Hantaan HTNV, Dobrava DOBV, Puumala PUUV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 278h-9601-1 G |
| ELISA | Anti-Hanta Virus Pool 1 "Eurasia" ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Hantaan HTNV, Dobrava DOBV, Puumala PUUV |
semi-quantitative | IgM |
96 x 01 |
EI 278h-9601-1 M |
| ELISA | Anti-Hanta Virus Pool 2 "America" ELISA (IgG) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 278h-9601-2 G |
| ELISA | Anti-Hanta Virus Pool 2 "America" ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
semi-quantitative | IgM |
96 x 01 |
EI 278h-9601-2 M |
| ELISA | Anti-Chikungunya Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant structural protein from Chikungunya virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 293a-9601 G |
| ELISA | Anti-Chikungunya Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant structural protein from Chikungunya virus |
semi-quantitative | IgM |
96 x 01 |
EI 293a-9601 M |
| ELISA | Anti-Mayaro Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant structural protein from Mayaro virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 295c-9601 G |
| ELISA | Anti-Mayaro Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant structural protein from Mayaro virus |
semi-quantitative | IgM |
96 x 01 |
EI 295c-9601 M |
| ELISA |
Dengue virus NS1 antigen detection (DENV) |
antibody-coated microplate wells |
Dengue virus NS1 (type 1-4) | 1/10/100 RU/ml |
96 x 01 |
EQ 266a-9601-1 | |
| IIFT | Zika virus (ZIKV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2668-1005 G FI 2668-1005 M FI 2668-1010 G FI 2668-1010 M |
|
| IIFT |
Arbovirus Fever Mosaic 2 Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2668-1005-1 G FI 2668-1005-1 M FI 2668-1010-1 G FI 2668-1010-1 M |
|
| IIFT |
Arbovirus Profile 3 upper row : Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) bottom row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
infected cells infected cells infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM |
10 x 05 10 x 05 |
FI 2668-1005-3 G FI 2668-1005-3 M |
|
| IIFT | Zika virus (ZIKV) EUROPattern |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 2668-1005 G FR 2668-1005 M FR 2668-1010 G FR 2668-1010 M |
|
| IIFT |
Arbovirus Fever Mosaic 2 EUROPattern Zika virus (ZIKV) Chikungunya virus (CHIKV) Dengue virus types 1 - 4 (DENV) |
6 BIOCHIPs per field: infected cells infected cells infected cells |
EU 14 EU 14 EU 14 |
IgG PI IgM PI IgG PI IgM PI |
10 x 05 10 x 05 10 x 10 10 x 10 |
FR 2668-1005-1 G FR 2668-1005-1 M FR 2668-1010-1 G FR 2668-1010-1 M |
|
| ELISA | Anti-Zika Virus ELISA (IgG) |
antigen-coated microplate wells |
recombinant NS1 antigen from Zika virus |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2668-9601 G |
| ELISA | Anti-Zika Virus ELISA (IgM) |
antigen-coated microplate wells |
recombinant NS1 antigen from Zika virus |
semi-quantitative | IgM |
96 x 01 |
EI 2668-9601 M |
| ELISA | Anti-Zika Virus ELISA (IgAM) |
antigen-coated microplate wells |
specific NS1 antigen from Zika virus |
semi-quantitative | IgAM |
96 x 01 |
EI 2668-9601 Q |
| ELISA |
Anti-MERS-CoV ELISA (IgG) Middle east respiratory syndrome coronavirus |
antigen-coated microplate wells |
recombinant S1 antigen of MERS coronavirus (MERS-CoV S1) |
semi-quantitative | IgG |
96 x 01 |
EI 2604-9601 G |
| ELISA |
Anti-SARS-CoV-2 ELISA (IgA) Severe acute respiratory syndrome coronavirus 2 |
antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
semi-quantitative | IgA |
96 x 01 |
EI 2606-9601 A |
| ELISA |
Anti-SARS-CoV-2 ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 |
antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
semi-quantitative | IgG |
96 x 01 |
EI 2606-9601 G |
| ELISA |
Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 |
1/10/20/40/80/120 RU/mL | IgG |
96 x 01 |
EI 2606-9601-10 G | ||
| ELISA |
Anti-SARS-CoV-2 NCP ELISA (IgG) Severe acute respiratory syndrome coronavirus 2 nucleocapsid protein |
semi-quantitative | IgG |
96 x 01 |
EI 2606-9601-2 G | ||
| ChLIA | Anti-SARS-CoV-2 RBD ChLIA (IgG) | Antigen-coated magnetic particles | quantitative | IgG |
100 x 1 |
LI 2606-10010-1 G | |
| ChLIA | Control set Anti-SARS-CoV-2 RBD ChLIA (IgG) | 2 x 0.5 ml control 1/2 | IgG |
02 x 02 |
LR 2606-20210-1 G | ||
| ELISA | Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgG) |
antigen-coated microplate wells |
recombinant protein from CCHFV |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 279a-9601 G |
| ELISA | Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgM) |
antigen-coated microplate wells |
recombinant protein from CCHFV |
semi-quantitative | IgM |
96 x 01 |
EI 279a-9601 M |
| IIFT | TBE virus (TBEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005 G FI 2661-1005 M FI 2661-1010 G FI 2661-1010 M |
|
| IIFT |
Flavivirus Mosaic 1 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005-1 G FI 2661-1005-1 M FI 2661-1010-1 G FI 2661-1010-1 M |
|
| IIFT |
Flavivirus Profile 2 upper row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) bottom row: Dengue virus types 1 - 4 (DENV) |
infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 |
FI 2661-1005-2 G FI 2661-1005-2 M FI 2661-2005-2 G FI 2661-2005-2 M |
|
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgG |
96 x 01 |
EI 2661-9601-2 G | |
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
semi-quantitative | IgM |
96 x 01 |
EI 2661-9601-2 M | |
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||